Related Experiment Video
Updated: Jun 8, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between
Diana Moldovan1, Ioan Moldovan, Crina Rusu
1Mihai Manasia Nephrology and Dialysis Clinic Cluj-Napoca, University of Medicine and Pharmacy Cluj-Napoca, Nephrology Clinic 3-5 Clinics Street, 400006 Cluj-Napoca, Romania. Diana.Moldovan@umfcluj.ro
Insights
Vascular calcifications (VCs) and renal osteodystrophy (ROD) are common in hemodialysis patients. ROD, male gender, and calcium salt treatment are risk factors for developing VCs, suggesting a link between bone and artery disease.
Area of Science:
- Nephrology
- Cardiology
- Bone Metabolism
Background:
- Vascular calcifications (VCs) and renal osteodystrophy (ROD) are prevalent complications in hemodialysis (HD) patients.
- These conditions significantly contribute to morbidity and mortality in this population.
- A potential pathogenic link between VCs and ROD remains debated.
Purpose of the Study:
- To investigate the relationship between VCs and ROD in chronic HD patients.
- To evaluate the prevalence of VCs and ROD.
- To identify clinical and biochemical factors associated with VCs in HD patients.
Main Methods:
- Radiological assessment of VCs and ROD using hand and pelvis bone radiographs in 81 chronic HD patients.
- Calculation of a vascular calcification (VC) score.
- Correlation and regression analyses to determine associations between VCs, ROD, and clinical/biochemical parameters.
Main Results:
- A significant association was found between radiological signs of ROD and VCs (P = 0.019).
- Patients with ROD exhibited a higher mean VC score (P = 0.02).
- VC score correlated with serum calcium, phosphorus, iPTH, CaxP product, and inversely with albumin. ROD, male gender, and calcium salt treatment predicted VCs.
Conclusions:
- A pathogenic link between bone disease (ROD) and arterial disease (VCs) is suggested in chronic HD patients.
- Both VCs and ROD are highly prevalent in this cohort.
- ROD, male gender, and calcium salt treatment are identified as risk factors for VCs.
Introduction:
Vascular calcifications (VCs) and renal osteodystrophy (ROD) are frequently seen together and represent the major causes of morbidity and mortality in hemodialysis (HD) patients. Some studies suggest a pathogenic link between them, but there is no consensus as yet regarding this issue. The main objective of our study was to establish whether there is any relation between VCs and ROD in our HD patients. We evaluated the prevalence of VCs and ROD and the relationship between VCs and some clinical and biochemical characteristics of HD patients.
Methods:
We examined radiological signs of VCs and ROD on hands and pelvis bone radiographs in 81 chronic HD patients, and we calculated a VC score on this basis.
Results:
We found a significant relation between radiological signs of ROD and those of VC (P = 0.019). The patients with ROD had a higher mean VC score (P = 0.02). By linear regression, the VC score correlated directly with serum calcium (Ca), phosphorus (P), intact parathyroid hormone (iPTH) and CaxP product and inversely with serum albumin. The logistic regression model revealed that ROD, male gender and treatment with calcium salts were predictive of VCs development. There were no associations between VCs and age, HD vintage, diabetes, dialysate Ca concentration, vitamin D treatment, spKt/V, URR and C-reactive protein (CRP) levels.
Conclusion:
There seems to be a pathogenetic link between bone and artery diseases in chronic HD patients. Both VCs and ROD have a high prevalence. ROD, male gender and treatment with calcium salts are risk factors for VCs.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Skeleton and Calcium Homeostasis
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease III: Interprofessional Care
Osteoclasts in Bone Remodeling
Urinary Tract Calculi I: Introduction

